Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis
Background The prognostic value of C-reactive protein (CRP) in patients with bladder cancer (BCa) has been widely analysed; however, the results remain conflicting. Therefore, we performed this meta-analysis to identify the precise role of CRP level in predicting BCa prognosis.Methods PubMed, Web of...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2024.2445781 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850088646825213952 |
|---|---|
| author | Xiangping Feng Zongxin Zhang Shuiying Mao |
| author_facet | Xiangping Feng Zongxin Zhang Shuiying Mao |
| author_sort | Xiangping Feng |
| collection | DOAJ |
| description | Background The prognostic value of C-reactive protein (CRP) in patients with bladder cancer (BCa) has been widely analysed; however, the results remain conflicting. Therefore, we performed this meta-analysis to identify the precise role of CRP level in predicting BCa prognosis.Methods PubMed, Web of Science, Embase and Cochrane Library databases were comprehensively searched until 19 April 2024. The impact of CRP level on predicting the prognosis of patients with BCa was examined using combined hazard ratios (HRs) and 95% confidence intervals (CIs). The relationship between CRP level and BCa clinicopathological characteristics was investigated by combining the odds ratios (ORs) with 95%CIs.Results Twenty studies with 7276 patients were enrolled in this study. As revealed by pooled data, elevated CRP levels were markedly related to poor overall survival (OS) (HR = 2.02, 95%CI = 1.41–2.90, p < .001), inferior cancer-specific survival (CSS) (HR = 1.46, 95%CI = 1.29–1.66, p < .001), shortened recurrence-free survival (RFS) (HR = 1.25, 95%CI = 1.17–1.33, p < .001) and dismal progression-free survival (PFS) (HR = 2.28, 95%CI = 1.80–2.90, p < .001) in BCa patients. Nevertheless, there was no significant relationship between CRP level and sex, tumour size, tumour grade or lymph node metastasis (LNM) in BCa.Conclusions Elevated CRP levels were significantly related to poor OS, CSS, RFS and PFS of BCa patients with BCa. CRP could act as a reliable biomarker for predicting the short- and long-term survival of patients with BCa in clinical practice. |
| format | Article |
| id | doaj-art-0f4cba7e893c401aa4d949069b0ed4d3 |
| institution | DOAJ |
| issn | 0785-3890 1365-2060 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Annals of Medicine |
| spelling | doaj-art-0f4cba7e893c401aa4d949069b0ed4d32025-08-20T02:42:59ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2024.2445781Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysisXiangping Feng0Zongxin Zhang1Shuiying Mao2Clinical Laboratory, Huzhou Maternity & Child Health Care Hospital, Huzhou, ChinaClinical Laboratory, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, Huzhou, ChinaClinical Laboratory, Huzhou Maternity & Child Health Care Hospital, Huzhou, ChinaBackground The prognostic value of C-reactive protein (CRP) in patients with bladder cancer (BCa) has been widely analysed; however, the results remain conflicting. Therefore, we performed this meta-analysis to identify the precise role of CRP level in predicting BCa prognosis.Methods PubMed, Web of Science, Embase and Cochrane Library databases were comprehensively searched until 19 April 2024. The impact of CRP level on predicting the prognosis of patients with BCa was examined using combined hazard ratios (HRs) and 95% confidence intervals (CIs). The relationship between CRP level and BCa clinicopathological characteristics was investigated by combining the odds ratios (ORs) with 95%CIs.Results Twenty studies with 7276 patients were enrolled in this study. As revealed by pooled data, elevated CRP levels were markedly related to poor overall survival (OS) (HR = 2.02, 95%CI = 1.41–2.90, p < .001), inferior cancer-specific survival (CSS) (HR = 1.46, 95%CI = 1.29–1.66, p < .001), shortened recurrence-free survival (RFS) (HR = 1.25, 95%CI = 1.17–1.33, p < .001) and dismal progression-free survival (PFS) (HR = 2.28, 95%CI = 1.80–2.90, p < .001) in BCa patients. Nevertheless, there was no significant relationship between CRP level and sex, tumour size, tumour grade or lymph node metastasis (LNM) in BCa.Conclusions Elevated CRP levels were significantly related to poor OS, CSS, RFS and PFS of BCa patients with BCa. CRP could act as a reliable biomarker for predicting the short- and long-term survival of patients with BCa in clinical practice.https://www.tandfonline.com/doi/10.1080/07853890.2024.2445781C-reactive proteinbladder cancermeta-analysisprognosisbiomarker |
| spellingShingle | Xiangping Feng Zongxin Zhang Shuiying Mao Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis Annals of Medicine C-reactive protein bladder cancer meta-analysis prognosis biomarker |
| title | Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis |
| title_full | Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis |
| title_fullStr | Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis |
| title_full_unstemmed | Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis |
| title_short | Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis |
| title_sort | prognostic and clinicopathological value of c reactive protein in patients with bladder cancer a meta analysis |
| topic | C-reactive protein bladder cancer meta-analysis prognosis biomarker |
| url | https://www.tandfonline.com/doi/10.1080/07853890.2024.2445781 |
| work_keys_str_mv | AT xiangpingfeng prognosticandclinicopathologicalvalueofcreactiveproteininpatientswithbladdercancerametaanalysis AT zongxinzhang prognosticandclinicopathologicalvalueofcreactiveproteininpatientswithbladdercancerametaanalysis AT shuiyingmao prognosticandclinicopathologicalvalueofcreactiveproteininpatientswithbladdercancerametaanalysis |